S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

NCT01959139 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

126

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Pancreatic Adenocarcinoma

Interventions

DRUG: PEGPH20
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: Irinotecan
DRUG: 5-fluorouracil

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]